Suppr超能文献

综述:协同性咽炎生物标志物的诊断潜力。

Review: Diagnostic Potential for Collaborative Pharyngitis Biomarkers.

机构信息

Department of Pathology and Laboratory Medicine, Medical College of Wisconsin, Milwaukee.

Medavera, Inc, Springfield, Missouri.

出版信息

J Infect Dis. 2024 Oct 23;230(Supplement_3):S190-S196. doi: 10.1093/infdis/jiae416.

Abstract

Pharyngitis is an inflammatory condition of the pharynx and/or tonsils commonly seen in both children and adults. Viruses and bacteria represent the most common encountered etiologic agents-yeast/fungi and parasites are infrequently implicated. Some of these are predominantly observed in unique populations (eg, immunocompromised or unvaccinated individuals). This manuscript (part 3 of 3) summarizes the current state of biomarker diagnostic testing and highlights the expanding role they will likely play in the expedited diagnosis and management of patients with acute pharyngitis. Biomarkers, in conjunction with rapid antigen and/or nucleic acid amplification testing, will likely become the standard of care to accurately diagnose the etiologic agent(s) of pharyngitis. This novel testing paradigm has the potential to guide appropriate patient management and antibiotic stewardship by accurately determining if the cause of pharyngitis is due to a viral or bacterial etiology.

摘要

咽炎是一种常见于儿童和成人的咽部和/或扁桃体炎症。病毒和细菌是最常见的病因,而酵母/真菌和寄生虫则很少涉及。其中一些主要见于特定人群(例如,免疫功能低下或未接种疫苗的个体)。本手稿(共 3 部分)总结了目前生物标志物诊断检测的现状,并强调了它们在加速急性咽炎患者诊断和治疗方面可能发挥的作用。生物标志物与快速抗原和/或核酸扩增检测相结合,可能成为准确诊断咽炎病因的标准。这种新的检测模式有可能通过准确确定咽炎的病因是病毒还是细菌,从而指导患者的适当管理和抗生素管理。

相似文献

3
Review: Known, Emerging, and Remerging Pharyngitis Pathogens.综述:已知、新兴和再现的咽炎病原体。
J Infect Dis. 2024 Oct 23;230(Supplement_3):S173-S181. doi: 10.1093/infdis/jiae391.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验